New functionalities in Orphanet for orphan drugs, R&D and marketing authorisations to better serve the rare diseases community

Documenti analoghi

• Rare diseases research in Europe: an overview based on data from the Orphanet database
  di: Martin, Natalia, et al.
  Pubblicazione: (2010)
• Orphanet Journal of Rare Diseases: Launch Editorial
  di: Aymé, Ségolène, et al.
  Pubblicazione: (2006)
• The influence of the European paediatric regulation on marketing authorisation of orphan drugs for children
  di: Kreeftmeijer-Vegter, Annemarie Rosan, et al.
  Pubblicazione: (2014)
• Evolution of national and European policies in the field of rare diseases and their impact over the past five years
  di: Rodwell, Charlotte, et al.
  Pubblicazione: (2014)
• WHO International Classification of Diseases (ICD) Revision Process: incorporating rare diseases into the classification scheme: state of art
  di: Aymé, Ségolène, et al.
  Pubblicazione: (2010)